{"html":"<iframe src=\"https://hatenablog-parts.com/embed?url=https%3A%2F%2Funeyama.hatenadiary.jp%2Fentry%2F20101025%2Fp17\" title=\"\u305d\u306e\u4ed6\u30cb\u30e5\u30fc\u30b9 - \u98df\u54c1\u5b89\u5168\u60c5\u5831blog\u904e\u53bb\u8a18\u4e8b\" class=\"embed-card embed-blogcard\" scrolling=\"no\" frameborder=\"0\" style=\"display: block; width: 100%; height: 190px; max-width: 500px; margin: 10px 0px;\"></iframe>","description":"Wall Street Journal\u304b\u3089 FDA\u306fArena\u306e\u6297\u80a5\u6e80\u85ac\u306b\u5bfe\u3057\u3066\u30c7\u30fc\u30bf\u3092\u8981\u6c42\u3001\u8981\u6c42\u6c34\u6e96\u306f\u9ad8\u3044 FDA Seeks Data on Arena Obesity Drug, Setting High Bar OCTOBER 24, 2010 http://online.wsj.com/article/SB10001424052702303864404575572163681743320.html lorcaserin\u306b\u3064\u3044\u3066 \u30a8\u30fc\u30b6\u30a4\u306e\u30d7\u30ec\u30b9\u30ea\u30ea\u30fc\u30b9\u304c\u51fa\u3066\u3044\u308b http://www.rsssuite.jp/eisairss/item_81107_2389250_4827.html \u2026","published":"2010-10-25 00:00:16","blog_url":"https://uneyama.hatenadiary.jp/","blog_title":"\u98df\u54c1\u5b89\u5168\u60c5\u5831blog\u904e\u53bb\u8a18\u4e8b","image_url":null,"height":"190","author_name":"uneyama","width":"100%","url":"https://uneyama.hatenadiary.jp/entry/20101025/p17","provider_url":"https://hatena.blog","version":"1.0","author_url":"https://blog.hatena.ne.jp/uneyama/","categories":[],"title":"\u305d\u306e\u4ed6\u30cb\u30e5\u30fc\u30b9","type":"rich","provider_name":"Hatena Blog"}